Mayo Clinic

With integrated data for thousands of TCGA tumors, teams explored cancer subtypes, searched for prognostic insights, began mapping immune cell interactions, and more.

Researchers saw clinically actionable heart disease mutations in fewer than 5 percent of sudden infant death syndrome cases interrogated by molecular autopsy.

Investigators identified mutation, expression, and methylation differences in colorectal polyps from individuals with or without colorectal cancer.

The partners are developing and optimizing an algorithm that assesses the likelihood of a patient's cancer progressing to metastasis.

Mayo Clinic is taking an ownership stake in sequencing startup Veritas Genetics as it integrates genomics expertise into the myGenome WGS platform.

The Mayo Clinic will apply PathoQuest's next-generation sequencing-based iDtect Blood test in a study to identify febrile neutropenia in patients.

Research teams documented mosaic mutations during brain development, as well as rising somatic mutations in aging brains or brains affected by neurodegenerative disease.